Paclitaxel and Cisplatin for Thymic Neoplasm 
      To assess the efficacy and safety of the regimen in previously untreated, unresectable
      invasive thymoma or thymic carcinoma
     Thymoma :

          -  histologically or cytologically confirmed invasive thymoma or thymic carcinoma

          -  unresectable tumor: by either local invasion, distant metastasis, or recurred
             (assessed by investigator)

          -  no previous systemic treatment for invasive thymoma or thymic carcinoma

          -  at least one measurable lesion by RECIST criteria

          -  18 years old or older

          -  ECOG performance status 0, 1, 2

          -  adequate lab. findings neutrophil ≥ 1.5 x 10^9/L platelet ≥ 75 x 10^9/L hemoglobin ≥
             9.0 g/dL bilirubin ≤ 1.5 x upper normal limit AST, ALT ≤ 2.5 x upper normal limit
             Alkaline phosphatase ≤ 2.5 x upper normal limit (if liver metastasis, ≤ 5 x upper
             normal limit) serum creatinine ≤ 1.0 x upper normal limit if serum creatinine > 1.0 x
             upper normal limit, creatinine clearance ≥ 60 mL/min

          -  patient who agree to written, informed consent

         :

          -  other malignancy (exception: non-melanoma skin cancer, cervical carcinoma in situ,
             cancer without evidence more than 5 years since curative resection)

          -  active bacterial infection

          -  history of clinical trial with investigational drug within 30 days

          -  radiotherapy to thoracic or mediastinal area (other area radiotherapy is permitted)

          -  pregnant, or lactating women

          -  patient with organ transplantation

          -  peripheral neuropathy, grade 2 or greater

          -  severe, medical condition unstable cardiac disease despite of adequate management
             myocardial infarction within 6 months active ulcer disease refractory to medication
             chronic obstructive lung disease requiring admission treatment within 1 year

          -  uncontrolled seizure, cerebral nervous system disorder, psychiatric problem which
             decrease treatment compliance
      